Sign in

Digital Jagran

Information, Information and Information

  1. Home
  2. /
  3. Biotech
  4. /
  5. Takeda Ends Denali Deal, Returns Dementia Drug in Strategic Reset
Back to News
Biotech

Takeda Ends Denali Deal, Returns Dementia Drug in Strategic Reset

Takeda exits its partnership with Denali Therapeutics, returning dementia drug DNL593 as part of a major restructuring plan involving layoffs and cost optimization.

S
Surya Pratap Singh
4/7/2026, 6:45:58 AM
Takeda Ends Denali Deal, Returns Dementia Drug in Strategic Reset
Share
0 min read

Digital Jagran

Your trusted source for the latest news, in-depth analysis, and perspectives from India and around the world — in both Hindi and English.

Sections

  • Politics
  • World
  • Business
  • Technology
  • Sports
  • Entertainment

Company

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Disclaimer

Subscribe

Stay updated with the latest news delivered to your inbox.

© 2026 Digital Jagran. All rights reserved.

PrivacyTermsDisclaimerContact
Home